EAM
ICPT
Eventide Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-501,033
| Closed | -$6.73M | – | 161 |
|
|
2023
Q1 | $6.73M | Sell |
501,033
-298,967
| -37% | -$4.02M | 0.12% | 126 |
|
|
2022
Q4 | $9.9M | Hold |
800,000
| – | – | 0.2% | 107 |
|
|
2022
Q3 | $11.2M | Hold |
800,000
| – | – | 0.22% | 102 |
|
|
2022
Q2 | $11M | Hold |
800,000
| – | – | 0.24% | 94 |
|
|
2022
Q1 | $13M | Buy |
800,000
+472,556
| +144% | +$7.69M | 0.2% | 103 |
|
|
2021
Q4 | $5.33M | Buy |
+327,444
| New | +$5.33M | 0.07% | 131 |
|
|
2020
Q1 | – | Sell |
-100,000
| Closed | -$12.4M | – | 133 |
|
|
2019
Q4 | $12.4M | Buy |
+100,000
| New | +$12.4M | 0.35% | 71 |
|
|
2019
Q2 | – | Sell |
-205,000
| Closed | -$22.9M | – | 135 |
|
|
2019
Q1 | $22.9M | Buy |
205,000
+37,000
| +22% | +$4.14M | 0.79% | 47 |
|
|
2018
Q4 | $16.9M | Buy |
+168,000
| New | +$16.9M | 0.75% | 49 |
|